SUMMARY: Pharma company influencers need to change the culture of pharma companies and take away the focus from Wall Street to patients.Continue reading
SUMMARY: According to eMarketer: The US healthcare and pharma industry will increase its digital ad spending by 20.1% to $3.62 billion in 2019. Uh..NO!Continue reading
SUMMARY: The Times said, “The drugmaker Novartis concealed manipulated data from the Food and Drug Administration while applying for approval of an extremely expensive gene therapy treatment and then delayed reporting the issue.” How could this happen in an industry that relies so much on meetings and data?Continue reading
SUMMARY: Consumer Protect looked at states where adults engage “in zero physical leisure activity,” which they dubbed the “Couch Potato Index.” Kentucky was No. 1, with 34.4 percent of adults in the state engaging in zero physical activity. Mississippi and Arkansas followed behind with 33.2 percent and 32.5 percent, respectively. There are many obesity-related health conditions, namely heart disease, type 2 diabetes, some types of cancer and stroke, among other health ailments, according to the CDC. This is costing us ALL more healthcare dollars.Continue reading
SUMMARY: Health care is playing a prominent role at the start of the 2020 presidential primary season with Democratic candidates offering competing proposals aimed at expanding coverage to more Americans but what do American’s really think about healthcare?Continue reading
SUMMARY: According to the NY Times “McKinsey offered advice to a drug company on how to increase opioid sales at a time when abuse of its pain medicine was widespread. Earlier this month, the State of Massachusetts released new documents from 2013 that detailed McKinsey’s recommendations on how Purdue Pharma could “turbocharge” sales of its widely abused opioid OxyContin. The state said McKinsey advised Purdue to sharply increase sales visits to targeted doctors and to consider mail orders as a way to bypass pharmacies that had been tightening oversight of opioid prescriptions.Continue reading
SUMMARY: The prevalence, complexity, and costs of cancer are rising – yet, across healthcare, up to 20% of expenditure is thought to be spent on interventions that are deemed inefficient.9 There is thus an urgent need to ensure that cancer care is delivered
as efficiently as possible for the sustainability of our healthcare systems.